Eisai Co., Ltd.: all 644 studies
Page 7 of 7. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.
- An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With CapecitabineTerminatedNCT00165880Phase 2
- An Open Label Phase II Study of Indisulam in Combination With Irinotecan in Patients With Metastatic Colorectal Cancer Who Have Been Previously Treated With 5-Fluorouracil/Leucovorin and OxaliplatinCompletedNCT00165867Phase 2
- Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal CancerCompletedNCT00165854Phase 2
- Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary GeneralizationTerminatedNCT00165828Phase 4
- The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With DementiaCompletedNCT00165815Phase 3
- A Phase I Open Label Study of E7974 Administered on a Day 1 of 21-Day Cycle In Patients With Advanced Solid TumorsCompletedNCT00165802Phase 1
- Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular DementiaCompletedNCT00165763Phase 4
- Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD PatientsTerminatedNCT00165750Phase 4
- Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular DiseaseCompletedNCT00165737Phase 3
- Alzheimer's Disease Long-term Follow-up Study (ALF Study)CompletedNCT00165724Phase 4
- The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia.CompletedNCT00165711Phase 4
- A Comparative Study of KES524 in Patients With Obesity DiseaseCompletedNCT00165685Phase 3
- A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020CompletedNCT00165659Phase 2
- A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular CarcinomaTerminatedNCT00165633Phase 2/3
- A Randomized, Open, Parallel, Optimal Injection Rate-Finding Study for E7337 in Dynamic CT of the Liver in Patients With Liver DiseaseCompletedNCT00165620Phase 2
- Randomized, Open, Parallel, Active Controlled Study on Fracture Prevention in Antiosteoporosis Treatment (OF Study)CompletedNCT00165607Phase 4
- A Study of E7070 in Patients With Gastric CancerTerminatedNCT00165594Phase 1/2
- A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated EpilepsiesCompletedNCT00154076Phase 4
- E2007 Given as Adjunctive Therapy in Patients With Refractory Partial SeizuresCompletedNCT00144690Phase 2
- A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid MalignanciesCompletedNCT00130169Phase 1
- Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential HypertensionCompletedNCT00130156Phase 4
- A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole SodiumCompletedNCT00125736Phase 4
- Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During ColonoscopyCompletedNCT00125424Phase 2/3
- GPI 15715 For Sedation in the Intensive Care Unit (ICU) SettingCompletedNCT00125398Phase 2
- Study of Irofulven in Patients With Hormone-refractory Prostate CancerCompletedNCT00124566Phase 2
- Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid CancerCompletedNCT00124527Phase 2
- An Open-Label Study of E7974 Administered on Days 1, 8, and 15 of a 28-Day Cycle and Days 1 and 8 of a 21-Day Cycle in Patients With Solid MalignanciesCompletedNCT00121732Phase 1
- A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients With Advanced and/or Metastatic MelanomaCompletedNCT00121680Phase 1
- Safety and Efficacy of APD356 in the Treatment of ObesityCompletedNCT00116740Phase 2
- Safety and Efficacy of APD356 in the Treatment of ObesityCompletedNCT00104507Phase 2
- The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive ImpairmentCompletedNCT00103948Phase 2
- Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's DiseaseCompletedNCT00096473Phase 3
- Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing ProstatectomyCompletedNCT00090376Phase 2
- Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer PatientsCompletedNCT00080197Phase 2
- Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or LymphomaCompletedNCT00078637Phase 1
- Dose-Finding Study of E7070 in Combination With IrinotecanCompletedNCT00060567Phase 1
- A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell CarcinomaCompletedNCT00059735Phase 2
- Dose Response Study of Zonegran in Patients With Newly Diagnosed EpilepsyCompletedNCT00056576Phase 3
- Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)CompletedNCT00055146Phase 2
- Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma PatientsCompletedNCT00051012Phase 4
- Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) PatientsCompletedNCT00050999Phase 4
- Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung CancerCompletedNCT00050973Phase 3
- A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe SepsisCompletedNCT00046072Phase 2
- Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic CancerCompletedNCT00033735Phase 3